No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
VBIV VBI Vaccines
- 0.630
- +0.021+3.40%
Close Apr 18 16:00 ET
- 0.613
- -0.017-2.68%
Post 18:43 ET
17.90MMarket Cap-104P/E (TTM)
0.642High0.580Low179.98KVolume0.630Open0.609Pre Close110.94KTurnover0.68%Turnover RatioLossP/E (Static)28.43MShares3.47052wk High2.38P/B16.73MFloat Cap0.45052wk Low--Dividend TTM26.56MShs Float2360.907Historical High--Div YieldTTM10.18%Amplitude0.095Historical Low0.616Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Perceptive Advisors LLC - Had Previously Reported 5.8% Stake in VBI Vaccines as of Nov 17, 2023
Express News | Perceptive Advisors LLC Reports 4.4% Stake in VBI Vaccines as of April 16 - SEC Filing
Express News | VBI Vaccines Inc : Raymond James Cuts Target Price to $5 From $6
VBI Vaccines FY Non-GAAP EPS of $3.96
VBI Vaccines Soars With Hepatitis B Vaccine Success
VBI Vaccines 2023 Rev $8.7M >VBIV
VBI Vaccines 2023 Rev $8.7M >VBIV
Comments
$VBI Vaccines(VBIV.US$
NEWS
VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
NEWS
VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
$VBI Vaccines(VBIV.US$ invest on your own risk, good luck.
$VBI Vaccines(VBIV.US$
NEWS
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
VBI Vaccines Inc. (VBIV) announces a registered direct offering of 2,272,728 common shares at $0.88 per share and unregistered warrants to purchase up to 2,272,728 common shares with an exercise price of $0.76 per share.
NEWS
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
VBI Vaccines Inc. (VBIV) announces a registered direct offering of 2,272,728 common shares at $0.88 per share and unregistered warrants to purchase up to 2,272,728 common shares with an exercise price of $0.76 per share.
2
Vaccine Company Expands Partnership With The Government of Canada
How Canada's Investment in VBI Vaccines Could Revolutionize Global Health.
In an unprecedented move that underscores the importance of innovation in the fight against infectious diseases, VBI Vaccines Inc. has expanded its strategic partnership with the Government of Canada. This collaboration, supported by a generous funding injection from the Canadian Strategic Innovation Fund (SIF), promises to accelerate the development of grou...
In an unprecedented move that underscores the importance of innovation in the fight against infectious diseases, VBI Vaccines Inc. has expanded its strategic partnership with the Government of Canada. This collaboration, supported by a generous funding injection from the Canadian Strategic Innovation Fund (SIF), promises to accelerate the development of grou...
1
$VBI Vaccines(VBIV.US$ Moving nicely. This is ready. Accumulate
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg